Arsenal Medical’s AxioCore™ core-sheath nanofiber and microfiber technologies are constructed from known biomaterials and can be used for cell integration and tissue regeneration and enabling controlled delivery of a broad range of biologics and therapeutics. Process advancements in slit-surface electrospinning enable high-throughput manufacturing of core-sheath fibers and innovative biomaterials.
The power of AxioCore™ lies in the platform's unique combination of attributes contributing to its potential therapeutic impact
- Versatile form factor for customized product design suited to each target implant location (e.g. joints, gut)
Flexible core-sheath structure for exceptional control of biologic and small-molecule drug delivery, and single- or multi-agent therapy
Porous microarchitecture for precise control of cellular in-growth ideal for tissue regeneration and repair
Arsenal's innovative electrospinning process enhances the feasibility of core-sheath fiber manufacturing, from a broad array of biomaterials. Our proprietary high-throughput fabrication method generates fibers 400 times faster than traditional electrospinning.
Data on Arsenal's novel electrospinning process was presented at the 2012 Fall Fiber Society Meeting.